SCHEMBL24857397

SCHEMBL24857397

CC(=O)c1c(C)nc2c(C(C)(C)C)cccn12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.55
ALDH1A1 P00352 4/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
CYP1A2 P05177 1/20 0.41
GUCY1B2 O75343 5/20 0.41
GUCY1A2 P33402 5/20 0.41
GUCY1A1 Q02108 5/20 0.41
GUCY1B1 Q02153 5/20 0.41
MAPT P10636 2/20 0.39
MAPK1 P28482 2/20 0.39
HCRTR1 O43613 1/20 0.39
TP53 P04637 1/20 0.39
ALOX15 P16050 1/20 0.39
RAB9A P51151 1/20 0.39
KDM4E B2RXH2 2/20 0.38
GAA P10253 1/20 0.38
LMNA P02545 1/20 0.36
GLA P06280 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3551654 0.83 ALDH1A1 (0.67) KMT2AALDH1A1SMN1; SMN2CYP1A2MAPT
SCHEMBL6351874 0.80 KMT2A (0.56) KMT2AALDH1A1SMN1; SMN2CYP1A2GUCY1B2
SCHEMBL7989395 0.80 KMT2A (0.56) KMT2AALDH1A1SMN1; SMN2CYP1A2GUCY1B2
SCHEMBL7978626 0.78 KMT2A (0.54) KMT2AALDH1A1SMN1; SMN2GUCY1B2GUCY1A2
SCHEMBL17018449 0.74 SMN1; SMN2 (0.56) KMT2AALDH1A1SMN1; SMN2CYP1A2GUCY1B2
SCHEMBL24858415 0.74 KMT2A (0.39) KMT2AALDH1A1SMN1; SMN2CYP1A2MAPT
SCHEMBL9080957 0.72 KMT2A (0.46) KMT2AALDH1A1SMN1; SMN2MAPTRAB9A
SCHEMBL24857765 0.72 KDM4E (0.60) KMT2AALDH1A1SMN1; SMN2CYP1A2GUCY1B2
SCHEMBL196599 0.71 KMT2A (1.00) KMT2AALDH1A1SMN1; SMN2MAPTMAPK1
SCHEMBL8315301 0.71 KMT2A (1.00) KMT2AALDH1A1SMN1; SMN2MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230002414-A1 AZAHETEROARYL COMPOUND AND APPLICATION THEREOF SHANGHAI BLUERAY BIOPHARMA CO., LTD. (CN) 2023-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002414-A1 AZAHETEROARYL COMPOUND AND APPLICATION THEREOF EZH2, EED, SUZ12 KMT2A 85/4885ALDH1A1 1813/4885SMN1; SMN2 1471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.